Namocell Appoints VP of Engineering

Mountain View, Calif., (October 30, 2019) – Namocell Inc., a leading provider of single cell sorting and dispensing platforms to advance single cell research and development, announced that Dr. Bob Cao has joined the company as VP of Engineering.

Bob brings over 20 years of engineering and innovation leadership experience. He spent 12 years at BD Biosciences, where he led the optical and opto-mechanical engineering team in developing and successfully implementing multiple flow cytometry products, including RUO/IVD analyzers and sorters, such as FACSVerse, FACSLyric and FACSMelody. He also served as technical lead of key technology development for next-gen instrument platforms. In addition to BD, Bob has held product development lead roles at 10x Genomics and Complete Genomics, including the development of ultra-high-throughput Next-Generation Sequencing (NGS) instrument.

“Namocell’s technology is a game changer for how people do single cell discovery and development. The unique combination of flow cytometry, microfluidics and liquid dispensing technologies provides users a fast, efficient and unprecedentedly easy way to isolate single cells at their benchtops,” said Bob Cao. “I am very excited to join the company and to have the opportunity to further expand our product portfolio.”

“I am really delighted to welcome Bob to the Namocell leadership team,” said Dr. Junyu Lin, CEO of Namocell.  “With his decades of experience in optical systems engineering, new product innovation, and proven success in the development of some of the industry’s most influential flow cytometry products, Bob is perfectly suited to advancing our product roadmap as we continue to get our products to more users to empower them to isolate single cells in the fastest and most efficient way.”

About Namocell

Namocell is a leading provider of single cell sorting and dispensing platforms to advance single cell research and development.  Namocell’s single cell dispensers provide the fastest and easiest way to identify and isolate single cells, and enable users to accomplish single cell sorting and dispensing in one step in a way that is gentle to live cells.  We serve researchers and scientists in a wide range of applications, including single cell genomics, cell line development, CRISPR, cell therapy, stem cell, monoclonal antibody development, rare cell isolation, and synthetic biology.  Learn more at www.namocell.com.